Pfizer

Trump thanks Novartis, Pfizer for not raising drug prices
Trump thanks Novartis, Pfizer for not raising drug prices
Yahoo/Reuters
Donald Trump
drug pricing
Novartis
Pfizer
Flag link:
Eli Lilly, Pfizer celebrate a PhIII success for their blockbuster pain drug contender tanezumab — but questions linger
Eli Lilly, Pfizer celebrate a PhIII success for their blockbuster pain drug contender tanezumab — but questions linger
Endpoints
Eli Lilly
Pfizer
anti-NGF
tanezumab
Flag link:
Pfizer's Hemophilia B Gene Therapy Candidate Enters Phase III
Pfizer's Hemophilia B Gene Therapy Candidate Enters Phase III
Zacks.com
Pfizer
hemophilia B
gene therapy
fidanacogene elaparvovec
Flag link:
Pfizer halts production at India injectables plant after FDA again finds issues
Pfizer halts production at India injectables plant after FDA again finds issues
Fierce Pharma
Pfizer
Hospira
drug manufacturing
FDA
Flag link:
Viagra: A Complicated Case Study of Generic Drug Market Entry in the United States
Viagra: A Complicated Case Study of Generic Drug Market Entry in the United States
Drug Patent Watch
Pfizer
Viagra
generics
Flag link:
Pfizer's Xtandi Gets FDA Nod for Expanded Patient Population
Pfizer's Xtandi Gets FDA Nod for Expanded Patient Population
Yahoo/Zacks.com
Pfizer
FDA
Astellas
Xtandi
prostate cancer
Flag link:
Many Drugmakers Ignore Trump—and Raise Prices Anyway
Many Drugmakers Ignore Trump—and Raise Prices Anyway
Bloomberg
drug pricing
Donald Trump
Pfizer
Celgene
Roche
Novo Nordisk
Flag link:
Pfizer’s Hospira Site in India Lands Another FDA Form 483
Pfizer’s Hospira Site in India Lands Another FDA Form 483
RAPS.org
FDA
Pfizer
Hospira
drug manufacturing
Flag link:
3 Key Lessons From Trump's Drug Price Feud With Pfizer
3 Key Lessons From Trump's Drug Price Feud With Pfizer
Fortune
Pfizer
Donald Trump
drug pricing
Flag link:
With Revlimid and Pomalyst price increases, could Celgene be next on Trump’s to-call list?
With Revlimid and Pomalyst price increases, could Celgene be next on Trump’s to-call list?
Fierce Pharma
Pfizer
Celgene
drug pricing
Donald Trump
Revlimid
Pomalyst
Flag link:
Sen. Wyden probes 'secret, sweetheart' deal between Pfizer, Trump
Sen. Wyden probes 'secret, sweetheart' deal between Pfizer, Trump
Fierce Pharma
Pfizer
drug pricing
Senate
Donald Trump
Ian Read
Pharma CEOs
Flag link:
4 Things You Need to Know About Pfizer's Restructuring Plans
4 Things You Need to Know About Pfizer's Restructuring Plans
Motley Fool
Pfizer
restructuring
M&A
consumer health
reorganization
Flag link:
What Pfizer, Trump, and consumers got out of a surprising deal — and what they didn’t
What Pfizer, Trump, and consumers got out of a surprising deal — and what they didn’t
Stat
Pfizer
drug pricing
Donald Trump
Flag link:
Pfizer reshuffles, splitting into three business units
Pfizer reshuffles, splitting into three business units
Endpoints
Pfizer
reorganization
consumer health
innovative medicines
innovation
Flag link:
Trump Phones, And Pfizer Reverses Price Hikes. But Why?
Trump Phones, And Pfizer Reverses Price Hikes. But Why?
Forbes
Donald Trump
Alex Azar
Pfizer
Ian Read
drug pricing
Flag link:
Trump lashes out against Pfizer over hiking of drug prices
Trump lashes out against Pfizer over hiking of drug prices
Stat
Donald Trump
Pfizer
drug pricing
Flag link:
FDA calls Pfizer Estring marketing misleading
FDA calls Pfizer Estring marketing misleading
Biopharma Dive
FDA
OPDP
Pfizer
Estring
drug ads
DTC ads
Flag link:
Pfizer raises prices on 100 drugs, its second round of hikes this year: FT
Pfizer raises prices on 100 drugs, its second round of hikes this year: FT
Fierce Pharma
Pfizer
drug pricing
Flag link:
FDA Grants Priority Review for Pfizer’s Glasdegib in Acute Myeloid Leukemia
FDA Grants Priority Review for Pfizer’s Glasdegib in Acute Myeloid Leukemia
CP Wire
Pfizer
glasdegib
acute myeloid leukemia
Flag link:
FDA Grants Priority Review for Pfizer’s Glasdegib in Acute Myeloid Leukemia
Pfizer
glasdegib
acute myeloid leukemia
Flag link:

Pages